Registry of Lobbyists

Monthly Communication Report

5246-630270

Organization: Medical Technology Association of Canada (Medtech Canada)/Association des technologies médicales du Canada
Associated registration: 950985-5246-26
Communication date: 2025-01-13
Posted date: 2025-02-05

Designated Public Office Holders who participated in the communication: Jonathan Alomoto, Senior Policy Advisor
Minister of International Trade, Global Affairs Canada (GAC)
 
List of Details
Subject matter Detail
Economic Development, Foreign Affairs, Government Procurement, Health, Industry, Research and Development, Science and Technology Discussions re. Policies to incent global medical technology companies to invest their R&D dollars in Canada, changes to the Scientific Research and Experimental Development tax credit and the impact on medical technology companies in Canada, the adoption of a common national framework to measuring health outcomes resulting in greater efficiencies and lower costs.
Economic Development, Federal-Provincial Relations, Government Procurement, Health, Industry, Research and Development, Science and Technology Innovation, Science and Economic Development Canada - advocating that the federal government work across all government relevant Ministries and with key stakeholders to advance the adoption of novel and innovative health innovations and grow the medical technology industry in Canada including forming a permanent cross ministerial and stakeholder collaborative roundtable/advisory group. Advocating for the development of a commercialization framework and adoption of medical technologies & health innovations strategy in Canada.
 
Responsible Officer who filed this communication report: Nicole DeKort
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 

Date Modified: